BioVie Inc at LifeSci Advisors Virtual Corporate Access Event Transcript
Good morning, everyone, and thank you for attending LifeSize 11th Annual Corporate Access Event. My name is Jason Laffin, and I'm a managing partner at LifeSci Consulting. I have the pleasure today of moderating this panel called The Best of Both Worlds: Defining Yourself When You Fit Into More Than One Basket. Today, we are going to be discussing how successful biotech companies navigate advancing two unrelated pipeline assets, and the key considerations encountered by management teams. These include decisions around resource and capital allocation, as well as asset prioritization, dialogue with the Board, and concisely communicating the story and strategic rationale to investors.
Joining me on this panel are Magnus Corefitzen, CEO of Ascelia Pharma, Cuong Do, CEO of BioVie, Carlos Buesa, CEO of Oryzon, and Marco Taglietti, CEO of SCYNEXIS. Today's session will last approximately 45 minutes, which will include a brief Q&A session at the end, time permitting. The audience can submit questions at the bottom of the window via the Q&A tab.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |